Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | GBA1 | P04062 | 2/20 | 0.38 |
| ▸ | GANAB | Q14697 | 1/20 | 0.38 |
| ▸ | SHBG | P04278 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | UGT2B7 | P16662 | 2/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12676496 | 0.95 | CA1 (0.38) | CA1CA2CA4GBA1GANAB | |
| SCHEMBL12676495 | 0.95 | CA1 (0.38) | CA1CA2CA4GBA1GANAB | |
| SCHEMBL12676494 | 0.95 | CA1 (0.38) | CA1CA2CA4GBA1GANAB | |
| SCHEMBL11730674 | 0.84 | CA1 (0.43) | CA1CA2CA4TP53 | |
| SCHEMBL6906317 | 0.82 | CA1 (0.42) | CA1CA2CA4SHBGTP53 | |
| SCHEMBL6909305 | 0.82 | CA1 (0.42) | CA1CA2CA4SHBGTP53 | |
| SCHEMBL12953219 | 0.80 | CA1 (0.43) | CA1CA2CA4GBA1SHBG | |
| SCHEMBL1133177 | 0.79 | CA1 (0.36) | CA1CA2CA4TP53KDM4E | |
| SCHEMBL18595189 | 0.78 | CA1 (0.41) | CA1CA2CA4GBA1SHBG | |
| SCHEMBL13625288 | 0.78 | TP53 (0.54) | CA1CA2CA4TP53KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10364348-B2 | Thermoplastic resin composition and molded article comprising the same | LOTTE ADVANCED MATERIALS CO., LTD. (KR) | 2019-07-30 | — | — | US | disclosed |
| EP-3135728-B1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE COMPRISING THE SAME | LOTTE ADVANCED MAT CO LTD (KR) | 2018-03-07 | — | — | EP | disclosed |
| US-20170058122-A1 | Thermoplastic Resin Composition and Molded Article Comprising the Same | LOTTE ADVANCED MATERIALS CO., LTD. (KR) | 2017-03-02 | — | — | US | disclosed |
| US-20170058121-A1 | Thermoplastic Resin Composition and Molded Article Comprising the Same | LOTTE ADVANCED MATERIALS CO., LTD. (KR) | 2017-03-02 | — | — | US | disclosed |
| EP-3135728-A1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE COMPRISING THE SAME | Lotte Advanced Materials Co., Ltd. (KR) | 2017-03-01 | — | — | EP | disclosed |
| EP-2459546-B1 | NEW BICYCLIC DIOXANES, THEIR PREPARATION AND THEIR USE AS FRAGRANT COMPOUNDS | MANE FILS V (FR) | 2013-12-18 | — | — | EP | disclosed |
| US-8569518-B2 | Bicyclic dioxanes, their preparation and their use as fragrant compounds | V. MANE FILS (FR) | 2013-10-29 | — | — | US | disclosed |
| US-20120165557-A1 | New Bicyclic Dioxanes, Their Preparation and Their Use as Fragrant Compounds | V. MANE FILS (FR) | 2012-06-28 | — | — | US | disclosed |
| EP-2459546-A1 | NEW BICYCLIC DIOXANES, THEIR PREPARATION AND THEIR USE AS FRAGRANT COMPOUNDS | V. Mane Fils (FR) | 2012-06-06 | — | — | EP | disclosed |
| EP-2287159-A1 | New bicyclic dioxanes, their preparation and their use as organoleptic compounds | V.Mane Fils (FR) | 2011-02-23 | — | — | EP | disclosed |
| WO-2011013077-A1 | NEW BICYCLIC DIOXANES, THEIR PREPARATION AND THEIR USE AS FRAGRANT COMPOUNDS | V. MANE FILS (FR) | 2011-02-03 | — | — | WO | disclosed |
| EP-1363893-A1 | PROCESS FOR PURIFICATION OF WARFARIN ACID, WARFARIN ALKALI METAL SALTS AND CORRESPONDING CLATHRATES | TARO PHARMACEUTICALS U.S.A., INC. (US) | 2003-11-26 | — | — | EP | disclosed |
| WO-2002070503-A1 | PROCESS FOR PURIFICATION OF WARFARIN ACID, WARFARIN ALKALI METAL SALTS AND CORRESPONDING CLATHRATES | TARO PHARMACEUTICALS U.S.A., INC. (US) | 2002-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165557-A1 | New Bicyclic Dioxanes, Their Preparation and Their Use as Fragrant Compounds | CBR3, CCNT1, C1R | CA1 3150/4885CA2 4073/4885CA4 3066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.